5 insights from JPM 2025
Based on JPM 2025, it’s safe to say that the biotech industry is experiencing a broad resurgence, with subtle yet significant disruption beneath the surface.
Blog
-
-
AI for biopharma business development: finding the right assets faster
By combining human expertise with AI-powered analysis, we’re helping biopharma companies make faster, more informed business development decisions.
-
3 key ways AI-powered analysis supports drug development
Artificial intelligence-powered pipeline analysis is emerging as a tool that can help teams make better, faster drug development decisions.
-
5 guardrails you MUST implement when using AI in biopharma
Implementing guardrails for artificial intelligence (AI) in biopharma is crucial for ensuring effective, safe, and compliant use of this powerful technology.
-
Biotech Limited Partners: learnings from investing in biotech venture capital funds
Limited Partners (LPs) are at the heart of the biotech funding ecosystem—these crucial players ignite the funding flywheel that drives biotech innovation.
-
4 common use cases for an AI-powered drug pipeline analysis platform
Let’s explore the four most common use cases for an AI-powered drug pipeline analysis platform and how they support strategic decision-making in biopharma.
-
What causes AI hallucinations & how Vibe Bio delivers results you can trust
Artificial Intelligence covers a range of algorithmic applications and outputs. Sometimes, AI hallucinates, so how does Vibe Bio deliver trustworthy outputs?
-
How can pharmaceutical companies improve pipeline analysis?
In biopharma, pipeline analysis provides comprehensive insights into the lifecycle of drug candidates, from discovery through clinical trials to market launch.
-
Enabling every cure for community matters: Our AI-powered journey
Vibe Bio is doing extraordinary work to change drug development: from funding next-generation therapies to helping others identify the highest potential cures.
-
4 major disruptions to the hunt for new cures, and how AI can help
The pursuit of novel cures in the pharmaceutical industry has always been a challenging endeavor. However, within the last decade or so, the landscape has become even more complex and disruptive due to several key factors. In this blog, we explore four major disruptions impacting the hunt for new cures and how artificial intelligence (AI)…
